直觉外科股价下挫与手术量指引不及预期相关——市场快讯

投资观察01-15

直觉外科公司尽管第四季度初步营收超预期，但股价仍遭遇抛售，这并不完全令人意外。Baird分析师David Rescott在报告中指出："2026财年手术量增长指引略低于市场买方已消化的预期。"他补充称，全球设备使用率增长环比持平，并提及"在医疗科技板块表现疲软的背景下，本周多数预披露企业存在下行倾向"。不过Rescott认为，该公司2026年指引可能偏向保守，这或为后续业绩超预期留下空间。直觉外科股价当前下跌3.8%。

（本文完）道琼斯通讯社

2026年1月14日12:44 ET（17:44 GMT）

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1179525047?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-01-15 01:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1179525047","market":"us","top_or_hot":-1,"title":"直觉外科股价下挫与手术量指引不及预期相关——市场快讯","media":"投资观察","content":"<p>直觉外科公司尽管第四季度初步营收超预期，但股价仍遭遇抛售，这并不完全令人意外。Baird分析师David Rescott在报告中指出：\"2026财年手术量增长指引略低于市场买方已消化的预期。\"他补充称，全球设备使用率增长环比持平，并提及\"在医疗科技板块表现疲软的背景下，本周多数预披露企业存在下行倾向\"。不过Rescott认为，该公司2026年指引可能偏向保守，这或为后续业绩超预期留下空间。直觉外科股价当前下跌3.8%。</p>\n<p>（本文完）道琼斯通讯社</p>\n<p>2026年1月14日12:44 ET（17:44 GMT）</p>\n<p>版权所有（c）2026 道琼斯公司</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>直觉外科股价下挫与手术量指引不及预期相关——市场快讯</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n直觉外科股价下挫与手术量指引不及预期相关——市场快讯\n</h2>\n\n<h4 class=\"meta\">\n\n2026-01-15 01:46 北京时间&nbsp;&nbsp;&nbsp;<strong>投资观察</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>直觉外科公司尽管第四季度初步营收超预期，但股价仍遭遇抛售，这并不完全令人意外。Baird分析师David Rescott在报告中指出：\"2026财年手术量增长指引略低于市场买方已消化的预期。\"他补充称，全球设备使用率增长环比持平，并提及\"在医疗科技板块表现疲软的背景下，本周多数预披露企业存在下行倾向\"。不过Rescott认为，该公司2026年指引可能偏向保守，这或为后续业绩超预期留下空间。直觉外科...</p>\n\n<a href=\"\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ISRG","symbol_name":"直觉外科公司","start_time":0,"source_url":"","article_id":"1179525047","we_media_id":"1076224072","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1179525047","pubTimestamp":1768412805,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"投资观察","introduction":"关注海外资本市场一手动态","home_visible":1,"id":"1076224072","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"summary":"直觉外科公司尽管第四季度初步营收超预期，但股价仍遭遇抛售，这并不完全令人意外。Baird分析师David Rescott在报告中指出：\"2026财年手术量增长指引略低于市场买方已消化的预期。\"他补充称，全球设备使用率增长环比持平，并提及\"在医疗科技板块表现疲软的背景下，本周多数预披露企业存在下行倾向\"。不过Rescott认为，该公司2026年指引可能偏向保守，这或为后续业绩超预期留下空间。直觉外科股价当前下跌3.8%。\n（本文完）道琼斯通讯社\n2026年1月14日12:44 ET（17:44 GMT）\n版权所有（c）2026 道琼斯公司","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"ISRG":"直觉外科公司","LU2125909593.SGD":"Natixis Thematics Meta R/A SGD","LU1868836591.USD":"CT (LUX) I AMERICAN \"1U\"(USD) ACC","IE00B19Z8W00.USD":"FTGF CLEARBRIDGE US LARGE CAP GROWTH \"A\" INC","LU1061106388.HKD":"BGF WORLD HEALTHSCIENCE \"A2\" (HKDHDG) ACC","LU0079474960.USD":"联博美国增长基金A","LU2106854487.HKD":"ALLIANZ THEMATICA \"AMG\" (HKD) INC","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","LU0390134368.USD":"FRANKLIN GLOBAL GROWTH \"A\" (USD) ACC","LU1868836757.USD":"CT (LUX) I AMERICAN FUND \"2\" (USD) ACC","LU0097036916.USD":"贝莱德美国增长A2 USD","IE00B5TLWC47.USD":"BNY MELLON LONG-TERM GLOBAL EQUITY \"B\" (USD) ACC","LU0882574055.USD":"富达全球健康医疗A ACC","IE00B19Z8X17.USD":"FTGF CLEARBRIDGE US LARGE CAP GROWTH  \"AG\" (USD) ACC","LU2265009873.SGD":"Eastspring Investments - Global Growth Equity AS SGD-H","BK4585":"ETF&股票定投概念","BK4534":"瑞士信贷持仓","LU1983299246.USD":"SCHRODER ISF HEALTHCARE INNOVATION \"A\" (USD) ACC","LU0823416689.USD":"BNP PARIBAS HEALTH CARE INNOVATORS \"C\" (USD) ACC","LU0096364046.USD":"CT (LUX) I AMERICAN \"DU\" (USD) ACC","LU1974910355.USD":"Allianz Thematica Cl AMg DIS USD","LU0122379950.USD":"贝莱德世界健康科学A2","LU2433249047.HKD":"THEMATICS META \"R/A\" (HKD) ACC","LU0823434583.USD":"BNP PARIBAS US GROWTH \"C\" (USD) ACC","IE00BYQQ9H92.USD":"BNY MELLON GLOBAL LEADERS \"A\" (USD) ACC","IE00B19Z9505.USD":"美盛-美国大盘成长股A Acc","LU1951198990.SGD":"Natixis Thematics AI & Robotics Fund H-R/A SGD-H","LU2063271972.USD":"富兰克林创新领域基金","LU2324357040.USD":"HSBC GIF GLOBAL EQUITY SUSTAINABLE HEALTHCARE \"AC\" (USD) ACC","LU0823434740.USD":"BNP PARIBAS US GROWTH \"C\" (USD) INC","LU0058720904.USD":"联博国际健康护理基金A","LU0354030511.USD":"ALLSPRING  U.S. LARGE CAP GROWTH \"I\" (USD) ACC","LU1951200564.SGD":"Natixis Thematics AI & Robotics Fund R/A SGD","BK4082":"医疗保健设备","LU0354030438.USD":"富国美国大盘成长基金Cl A Acc","LU1868837300.USD":"CT (LUX) I AMERICAN FUND \"9\" (USD) ACC","BK4504":"桥水持仓","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","BK4588":"碎股","LU1923623000.USD":"Natixis Thematics AI & Robotics Fund R/A USD","LU2023250504.SGD":"Allianz Thematica Cl AMg DIS H2-SGD","LU1989764664.SGD":"CPR Invest - Global Disruptive Opportunities A2 Acc SGD-H","LU2023250843.SGD":"Allianz Thematica Cl AT Acc H2-SGD","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","BK4548":"巴美列捷福持仓","LU1917777945.USD":"安联专题基金Cl AT Acc","LU1868836914.USD":"CT (LUX) I AMERICAN \"3\" (USD) ACC","LU2125909247.SGD":"Natixis Thematics Meta H-R/A SGD","LU1989764748.USD":"东方汇理环球颠覆性机遇A2 Acc","LU0061475181.USD":"THREADNEEDLE (LUX) AMERICAN \"AU\" (USD) ACC","LU1923622614.USD":"Natixis Thematics Meta R/A USD","IE00BFXG0V08.USD":"BNY MELLON GLOBAL LEADERS \"B\" (USD) ACC","LU0238689110.USD":"贝莱德环球动力股票基金","LU1804176565.USD":"EASTSPRING INV GLOBAL GROWTH EQUITY \"A\" (USD) ACC","LU2112291526.USD":"BGF WORLD HEALTHSCIENCE \"A4\" (USD) INC","LU1868837136.USD":"CT (LUX) I AMERICAN \"8\" (USD) ACC","LU1366192091.USD":"ALLIANZ US EQUITY PLUS \"AM\" (USD) INC"},"translate_title":"The decline in Intuitive Surgery's stock price is related to lower-than-expected surgery volume guidance-Market News","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ISRG":1},"content_text":"直觉外科公司尽管第四季度初步营收超预期，但股价仍遭遇抛售，这并不完全令人意外。Baird分析师David Rescott在报告中指出：\"2026财年手术量增长指引略低于市场买方已消化的预期。\"他补充称，全球设备使用率增长环比持平，并提及\"在医疗科技板块表现疲软的背景下，本周多数预披露企业存在下行倾向\"。不过Rescott认为，该公司2026年指引可能偏向保守，这或为后续业绩超预期留下空间。直觉外科股价当前下跌3.8%。\n（本文完）道琼斯通讯社\n2026年1月14日12:44 ET（17:44 GMT）\n版权所有（c）2026 道琼斯公司","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1179525047","isCrawlerRequest":true}